U.S. SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    Form 10-Q

Mark One
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
    ACT OF 1934

    For the quarterly period ended September 30, 2009

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
    ACT OF 1934

    For the transition period from ____________ to _____________

                         Commission File No. 333-149857

                                 Bio-Clean, Inc.
                 (Name of small business issuer in its charter)

           Nevada                                                26-0338889
(State or other jurisdiction of                               (I.R.S. Employer
 incorporation or organization)                              Identification No.)

                           895 Dove Street, 3rd Floor
                             Newport Beach, CA 92660
                    (Address of principal executive offices)

                                 (949) 955-7979
                          (Issuer's telephone number)

Securities registered pursuant to                          Name of each exchange
     Section 12(b) of the Act:                              on which registered:
                                      None

          Securities registered pursuant to Section 12(g) of the Act:

                             Common Stock, $0.00001
                                (Title of Class)

Indicate by check mark whether the registrant has submitted electronically and
posted on its corporate Web site, if any, every Interactive Data File required
to be submitted and posted pursuant to Rule 405 of Regulation S-T (ss.232.405 of
this chapter) during the preceding 12 months (or for such shorter period that
the registrant was required to submit and post such files). YES [X] NO [ ]

Indicate by checkmark whether the issuer: (1) has filed all reports required to
be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months
(or for such shorter period that the registrant was required to file such
reports), and (2) has been subject to such filing requirements for the past 90
days. Yes [X] No[ ]

Indicate by check mark whether the registrant is a large accelerated filed, an
accelerated filer, a non-accelerated filer, or a smaller reporting company.

Large accelerated filer [ ]                        Accelerated filer [ ]

Non-accelerated filer [X]                          Smaller reporting company [X]

Indicate by checkmark whether the registrant is a shell company (as defined in
Rule 12b-2 of the Exchange Act). Yes [ ] No [X]

          APPLICABLE ONLY TO ISSUER INVOLVED IN BANKRUPTCY PROCEEDINGS
                        DURING THE PRECEDING FIVE YEARS.

N/A

Indicate by checkmark whether the issuer has filed all documents and reports
required to be filed by Section 12, 13 and 15(d) of the Securities Exchange Act
of 1934 after the distribution of securities under a plan confirmed by a court.
Yes[ ] No[ ]

                    APPLICABLE ONLY TO CORPORATE REGISTRANTS

Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of the most practicable date:

      Class                                  Outstanding as of November 20, 2009
      -----                                  -----------------------------------
Common Stock, $0.00001                                 81,810,000
<PAGE>
                                 BIO-CLEAN, INC.

                                    FORM 10-Q

Part I.  FINANCIAL INFORMATION

Item 1.  Financial Statements                                                  3
           Balance Sheets                                                      3
           Statements of Operations                                            4
           Statements of Cash Flows                                            5
           Notes to Financial Statements                                       6

Item 2.  Management's Discussion and Analysis of Financial Condition
         and Results of Operations                                            11

Item 3.  Quantitative and Qualitative Disclosures About Market Risk           14

Item 4.  Controls and Procedures                                              14

Part II. OTHER INFORMATION

Item 1.  Legal Proceedings                                                    15

Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds          15

Item 3.  Defaults Upon Senior Securities                                      15

Item 4.  Submission of Matters to a Vote of Security Holders                  15

Item 5.  Other Information                                                    15

Item 6.  Exhibits                                                             15

                                       2
<PAGE>
                                     PART I

ITEM 1. FINANCIAL STATEMENTS

BIO-CLEAN,INC.
(A Development Stage Company)
Balance Sheet
--------------------------------------------------------------------------------

<TABLE>
<CAPTION>
                                                                       September 30,       December 31,
                                                                           2009               2008
                                                                         --------           --------
                                                                        (Unaudited)         (Audited)
<S>                                                                      <C>                <C>
                                     ASSETS

CURRENT ASSETS
  Cash                                                                   $  1,498           $ 15,783
                                                                         --------           --------

TOTAL ASSETS                                                             $  1,498           $ 15,783
                                                                         ========           ========

                      LIABILITIES AND STOCKHOLDERS' EQUITY

LONG TERM LIABILITIES
  Loan from Director                                                     $ 21,418           $    200
                                                                         --------           --------

TOTAL LONG TERM LIABILITIES                                                21,418                200
                                                                         --------           --------
STOCKHOLDERS' EQUITY
  Capital stock
    Common stock, $0.00001par value, 100,000,000 shares authorized;
     81,810,000 shares issued and outstanding                                 819                 91
  Additional paid-in-capital                                               53,181             53,909
  Deficit accumulated during the development stage                        (73,920)           (38,417)
                                                                         --------           --------

TOTAL STOCKHOLDERS' EQUITY                                                (19,920)            15,583
                                                                         --------           --------

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY                               $  1,498           $ 15,783
                                                                         ========           ========
</TABLE>


                 See Accompanying Notes to Financial Statements

                                       3
<PAGE>
BIO-CLEAN, INC.
(A Development Stage Company)
Statements of Operations
(Unaudited)
--------------------------------------------------------------------------------

<TABLE>
<CAPTION>
                                                                                                             Cumulative from
                                        Three Months       Nine Months     Three Months       Nine Months      May 22, 2007
                                           Ended             Ended            Ended             Ended         (Inception) to
                                        September 30,     September 30,    September 30,     September 30,     September 30,
                                            2009              2009             2008              2008              2009
                                        ------------      ------------     ------------      ------------      ------------
<S>                                     <C>               <C>              <C>               <C>               <C>
Expenses
  General and Administrative Expenses   $     20,867      $     35,503     $      3,315      $     25,369      $     73,920
                                        ------------      ------------     ------------      ------------      ------------

Net (loss)                              $    (20,867)     $    (35,503)    $     (3,315)     $    (25,369)     $    (73,920)
                                        ============      ============     ============      ============      ============

LOSS PER SHARE - BASIC AND DILUTED      $      (0.00)     $      (0.00)    $      (0.00)     $      (0.00)     $      (0.00)
                                        ============      ============     ============      ============      ============

WEIGHTED AVERAGE NUMBER OF COMMON
 SHARES OUTSTANDING                       81,810,000        81,810,000       81,810,000        81,810,000        81,810,000
                                        ============      ============     ============      ============      ============
</TABLE>


                 See Accompanying Notes to Financial Statements

                                       4
<PAGE>
BIO-CLEAN, INC.
(A Development Stage Company)
Statements of Cash Flows
(Unaudited)
--------------------------------------------------------------------------------

<TABLE>
<CAPTION>
                                                                                                 Cumulative from
                                                              Nine Months        Nine Months       May 22, 2007
                                                                Ended              Ended          (Inception) to
                                                             September 30,      September 30,      September 30,
                                                                 2009               2008               2009
                                                               --------           --------           --------
<S>                                                            <C>                <C>                <C>
CASH FLOWS FROM OPERATING ACTIVITIES
  Net (loss)                                                   $(35,503)          $(25,369)          $(73,920)
                                                               --------           --------           --------

      Net cash used for operating activities                    (35,503)           (25,369)           (73,920)
                                                               --------           --------           --------

CASH FLOWS FROM  (USED IN) FINANCING ACTIVITIES
  Loans from Director                                            21,218                 --             21,418
  Sale of common stock                                               --                 --             54,000
                                                               --------           --------           --------

      Net Cash provided by (used in) Financing Activities        21,218                 --             75,418
                                                               --------           --------           --------

Net increase (decrease) in cash and equivalents                 (14,185)           (22,054)             1,498

Cash and equivalents at beginning of the period                  15,783             43,632                 --
                                                               --------           --------           --------

Cash and equivalents at end of the period                      $  1,498           $ 21,578           $  1,498
                                                               ========           ========           ========

SUPPLEMENTAL CASH FLOW INFORMATION:

Cash paid for:
  Interest                                                     $     --           $     --           $     --
                                                               ========           ========           ========

  Taxes                                                        $     --           $     --           $     --
                                                               ========           ========           ========
</TABLE>


                 See Accompanying Notes to Financial Statements

                                       5
<PAGE>
BIO-CLEAN, INC.
(A Development Stage Company)
Notes To The Financial Statements
September 30, 2009
(Unaudited)
--------------------------------------------------------------------------------

1. ORGANIZATION AND BUSINESS OPERATIONS

BIO-CLEAN, INC., formerly NATURE OF BEAUTY LTD ("the Company") was incorporated
under the laws of the State of Nevada, U.S. on May 22, 2007. In September 2009
the Company changed in name to Bio-Clean, Inc. and effected a nine for one split
of its common stock. The Company is in the development stage as defined under
Statement on Financial Accounting Standards No. 7, Development Stage Enterprises
("SFAS No.7") and its efforts are primarily devoted marketing and distributing
beauty product to North American market. The Company has not generated any
revenue to date and consequently its operations are subject to all risks
inherent in the establishment of a new business enterprise. For the period from
inception, May 22, 2007 through September 30, 2009 the Company has accumulated
losses of $73,920.

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

a) Basis of Presentation

The financial statements have been prepared on a going concern basis which
assumes the Company will be able to realize its assets and discharge its
liabilities in the normal course of business for the foreseeable future. The
Company has incurred losses since inception resulting in an accumulated deficit
of $73,920 as of September 30, 2009 and further losses are anticipated in the
development of its business raising substantial doubt about the Company's
ability to continue as a going concern. The ability to continue as a going
concern is dependent upon the Company generating profitable operations in the
future and/or to obtain the necessary financing to meet its obligations and
repay its liabilities arising from normal business operations when they come
due. Management intends to finance operating costs over the next twelve months
with existing cash on hand and loans from directors and or private placement of
common stock. The financial statements of the Company have been prepared in
accordance with generally accepted accounting principles in the United States of
America and are presented in US dollars.

b) Cash and Cash Equivalents

The Company considers all highly liquid instruments with a maturity of three
months or less at the time of issuance to be cash equivalents.

c) Use of Estimates and Assumptions

The preparation of financial statements in conformity with accounting principles
generally accepted in the United States requires management to make estimates
and assumptions that affect the reported amounts of assets and liabilities and
disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of revenues and expenses during the
reporting period. Actual results could differ from those estimates.

                                       6
<PAGE>
d) Foreign Currency Translation

The Company's functional currency and its reporting currency is the United
States dollar.

e) Financial Instruments

The carrying value of the Company's financial instruments approximates their
fair value because of the short maturity of these instruments.

f) Stock-based Compensation

Stock-based compensation is accounted for at fair value in accordance with SFAS
No. 123 and 123 (R). To date, the Company has not adopted a stock option plan
and has not granted any stock options.

g) Income Taxes

Income taxes are accounted for under the assets and liability method. Deferred
tax assets and liabilities are recognized for the estimated future tax
consequences attributable to differences between the financial statement
carrying amounts of existing assets and liabilities and their respective tax
bases and operating loss and tax credit carry forwards. Deferred tax assets and
liabilities are measured using enacted tax rates in effect for the year in which
those temporary differences are expected to be recovered or settled.

h) Basic and Diluted Net Loss per Share

The Company computes net loss per share in accordance with SFAS No.
128,"Earnings per Share". SFAS No. 128 requires presentation of both basic and
diluted earnings per share (EPS) on the face of the income statement. Basic EPS
is computed by dividing net loss available to common shareholders (numerator) by
the weighted average number of shares outstanding (denominator) during the
period. Diluted EPS gives effect to all potentially dilutive common shares
outstanding during the period. Diluted EPS excludes all potentially dilutive
shares if their effect is anti-dilutive.

i) Fiscal Periods

The Company's fiscal year end is December 31.

j) Recent Accounting Pronouncements

In May 2008, the Financial Accounting Standards Board ("FASB") issued SFAS No.
163, "Accounting for Financial Guarantee Insurance Contracts-and interpretation

                                       7
<PAGE>
of FASB Statement No. 60". SFAS No. 163 clarifies how Statement 60 applies to
financial guarantee insurance contracts, including the recognition and
measurement of premium revenue and claims liabilities. This statement also
requires expanded disclosures about financial guarantee insurance contracts.
SFAS No. 163 is effective for fiscal years beginning on or after December 15,
2008, and interim periods within those years. SFAS No. 163 has no effect on the
Company's financial position, statements of operations, or cash flows at this
time.

In May 2008, the Financial Accounting Standards Board ("FASB") issued SFAS No.
162, "The Hierarchy of Generally Accepted Accounting Principles". SFAS No. 162
sets forth the level of authority to a given accounting pronouncement or
document by category. Where there might be conflicting guidance between two
categories, the more authoritative category will prevail. SFAS No. 162 will
become effective 60 days after the SEC approves the PCAOB's amendments to AU
Section 411 of the AICPA Professional Standards. SFAS No. 162 has no effect on
the Company's financial position, statements of operations, or cash flows at
this time.

In March 2008, the Financial Accounting Standards Board, or FASB, issued SFAS
No. 161, Disclosures about Derivative Instruments and Hedging Activities--an
amendment of FASB Statement No. 133. This standard requires companies to provide
enhanced disclosures about (a) how and why an entity uses derivative
instruments, (b) how derivative instruments and related hedged items are
accounted for under Statement 133 and its related interpretations, and (c) how
derivative instruments and related hedged items affect an entity's financial
position, financial performance, and cash flows. This Statement is effective for
financial statements issued for fiscal years and interim periods beginning after
November 15, 2008, with early application encouraged. The Company has not yet
adopted the provisions of SFAS No. 161, but does not expect it to have a
material impact on its consolidated financial position, results of operations or
cash flows.

In December 2007, the SEC issued Staff Accounting Bulletin (SAB) No. 110
regarding the use of a "simplified" method, as discussed in SAB No. 107 (SAB
107), in developing an estimate of expected term of "plain vanilla" share
options in accordance with SFAS No. 123 (R), Share-Based Payment. In particular,
the staff indicated in SAB 107 that it will accept a company's election to use
the simplified method, regardless of whether the company has sufficient
information to make more refined estimates of expected term. At the time SAB 107
was issued, the staff believed that more detailed external information about
employee exercise behavior (e.g., employee exercise patterns by industry and/or
other categories of companies) would, over time, become readily available to
companies. Therefore, the staff stated in SAB 107 that it would not expect a
company to use the simplified method for share option grants after December 31,
2007. The staff understands that such detailed information about employee
exercise behavior may not be widely available by December 31, 2007. Accordingly,
the staff will continue to accept, under certain circumstances, the use of the
simplified method beyond December 31, 2007. The Company currently uses the
simplified method for "plain vanilla" share options and warrants, and will
assess the impact of SAB 110 for fiscal year 2009. It is not believed that this
will have an impact on the Company's consolidated financial position, results of
operations or cash flows.

In December 2007, the FASB issued SFAS No. 160, Noncontrolling Interests in
Consolidated Financial Statements--an amendment of ARB No. 51. This statement
amends ARB 51 to establish accounting and reporting standards for the

                                       8
<PAGE>
noncontrolling interest in a subsidiary and for the deconsolidation of a
subsidiary. It clarifies that a noncontrolling interest in a subsidiary is an
ownership interest in the consolidated entity that should be reported as equity
in the consolidated financial statements. Before this statement was issued,
limited guidance existed for reporting noncontrolling interests. As a result,
considerable diversity in practice existed. So-called minority interests were
reported in the consolidated statement of financial position as liabilities or
in the mezzanine section between liabilities and equity. This statement improves
comparability by eliminating that diversity. This statement is effective for
fiscal years, and interim periods within those fiscal years, beginning on or
after December 15, 2008 (that is, January 1, 2009, for entities with calendar
year-ends). Earlier adoption is prohibited.

The effective date of this statement is the same as that of the related
Statement 141 (revised 2007). The Company will adopt this Statement beginning
March 1, 2009. It is not believed that this will have an impact on the Company's
consolidated financial position, results of operations or cash flows.

In December 2007, the FASB, issued FAS No. 141 (revised 2007), Business
Combinations.'This Statement replaces FASB Statement No. 141, Business
Combinations, but retains the fundamental requirements in Statement 141. This
Statement establishes principles and requirements for how the acquirer: (a)
recognizes and measures in its financial statements the identifiable assets
acquired, the liabilities assumed, and any noncontrolling interest in the
acquiree; (b) recognizes and measures the goodwill acquired in the business
combination or a gain from a bargain purchase; and (c) determines what
information to disclose to enable users of the financial statements to evaluate
the nature and financial effects of the business combination. This statement
applies prospectively to business combinations for which the acquisition date is
on or after the beginning of the first annual reporting period beginning on or
after December 15, 2008. An entity may not apply it before that date. The
effective date of this statement is the same as that of the related FASB
Statement No. 160, Noncontrolling Interests in Consolidated Financial
Statements. The Company will adopt this statement beginning March 1, 2009. It is
not believed that this will have an impact on the Company's consolidated
financial position, results of operations or cash flows.

In February 2007, the FASB, issued SFAS No. 159, The Fair Value Option for
Financial Assets and Liabilities--Including an Amendment of FASB Statement No.
115. This standard permits an entity to choose to measure many financial
instruments and certain other items at fair value. This option is available to
all entities. Most of the provisions in FAS 159 are elective; however, an
amendment to FAS 115 Accounting for Certain Investments in Debt and Equity
Securities applies to all entities with available for sale or trading
securities. Some requirements apply differently to entities that do not report
net income. SFAS No. 159 is effective as of the beginning of an entities first
fiscal year that begins after November 15, 2007. Early adoption is permitted as
of the beginning of the previous fiscal year provided that the entity makes that
choice in the first 120 days of that fiscal year and also elects to apply the
provisions of SFAS No. 157 Fair Value Measurements. The Company will adopt SFAS
No. 159 beginning March 1, 2008 and is currently evaluating the potential impact
the adoption of this pronouncement will have on its consolidated financial
statements.

                                       9
<PAGE>
In September 2006, the FASB issued SFAS No. 157, Fair Value Measurements This
statement defines fair value, establishes a framework for measuring fair value
in generally accepted accounting principles (GAAP), and expands disclosures
about fair value measurements. This statement applies under other accounting
pronouncements that require or permit fair value measurements, the Board having
previously concluded in those accounting pronouncements that fair value is the
relevant measurement attribute. Accordingly, this statement does not require any
new fair value measurements. However, for some entities, the application of this
statement will change current practice. This statement is effective for
financial statements issued for fiscal years beginning after November 15, 2007,
and interim periods within those fiscal years. Earlier application is
encouraged, provided that the reporting entity has not yet issued financial
statements for that fiscal year, including financial statements for an interim
period within that fiscal year. The Company will adopt this statement March 1,
2008, and it is not believed that this will have an impact on the Company's
consolidated financial position, results of operations or cash flows.

3. COMMON STOCK

The authorized capital of the Company is 200,000,000 common shares with a par
value of $ 0.00001 per share.

In July 2007, the Company issued 45,000,000 shares of common stock at a price of
$0.0001 per share for total cash proceeds of $5,000.

In August 2007, the Company issued 36,000,000 shares of common stock at a price
of $0.001 per share for total cash proceeds of $40,000.

In December 2007, the Company also issued 810,000 shares of common stock at a
price of $0.010 per share for total cash proceeds of $9,000.

During the period May 22, 2007 (inception) to December 31, 2007, the Company
sold a total of 81,81,000 shares of common stock for total cash proceeds of
$54,000.

In September 2009 the Company forward split its common shares 9 for 1. The above
amounts reflect this split.

4. INCOME TAXES

As of September 30, 2009, the Company had net operating loss carry forwards of
approximately $73,920 that may be available to reduce future years' taxable
income through 2029. Future tax benefits which may arise as a result of these
losses have not been recognized in these financial statements, as their
realization is determined not likely to occur and accordingly, the Company has
recorded a valuation allowance for the deferred tax asset relating to these tax
loss carry-forwards.

5. RELATED PARTY TRANSACTONS

On February 6, 2009 the Company repaid $100 to related party and in the third
quarter of 2009 a related party advanced $20,318 to the Company.

                                       10
<PAGE>
                           FORWARD LOOKING STATEMENTS

Statements made in this Form 10-Q that are not historical or current facts are
"forward-looking statements" made pursuant to the safe harbor provisions of
Section 27A of the Securities Act of 1933 (the "Act") and Section 21E of the
Securities Exchange Act of 1934. These statements often can be identified by the
use of terms such as "may," "will," "expect," "believe," "anticipate,"
"estimate," "approximate" or "continue," or the negative thereof. We intend that
such forward-looking statements be subject to the safe harbors for such
statements. We wish to caution readers not to place undue reliance on any such
forward-looking statements, which speak only as of the date made. Any
forward-looking statements represent management's best judgment as to what may
occur in the future. However, forward-looking statements are subject to risks,
uncertainties and important factors beyond our control that could cause actual
results and events to differ materially from historical results of operations
and events and those presently anticipated or projected. We disclaim any
obligation subsequently to revise any forward-looking statements to reflect
events or circumstances after the date of such statement or to reflect the
occurrence of anticipated or unanticipated events.

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
        OF OPERATION

GENERAL

BIO-CLEAN, INC., formerly NATURE OF BEAUTY LTD., is a corporation organized
under the laws of the State of Nevada. Our registration statement has been filed
with the Securities and Exchange Commission and has been declared effective on
May 21, 2008.

Our core business is the wholesaling of natural and organic cleaning and
disinfecting solutions.

We are currently developing our website, which will enable our clients to
educate themselves about our products and be able to place orders on-line. This
should increase our potential sales and lower the cost of marketing. We believe
that we will generate revenues from the following once our website is completed:
a) Direct sales to clients b) banner advertising from new manufacturers
launching new products and c) other existing entities with whom we will
negotiate exclusive distribution of different products.

Please note that throughout this Quarterly Report, and unless otherwise noted,
the words "we," "our," "us," the "Company," or "Bio-Clean," refers to Bio-Clean,
Inc.

RESULTS OF OPERATION

We are a development stage company and have not generated any revenue to date.
We have incurred recurring losses to date. Our financial statements have been
prepared assuming that we will continue as a going concern and, accordingly, do
not include adjustments relating to the recoverability and realization of assets
and classification of liabilities that might be necessary should we be unable to
continue in operation. We expect we will require additional capital to meet our
long term operating requirements. We expect to raise additional capital through,
among other things, the sale of equity or debt securities.

                                       11
<PAGE>
The summarized financial data is derived from and should be read in conjunction
with our unaudited financial statements for the six-month period ended September
30, 2009, including the notes to those financial statements which are included
in this Quarterly Report. The following discussion contains forward-looking
statements that reflect our plans, estimates and beliefs. Our actual results
could differ materially from those discussed in the forward-looking statements.
Our audited financial statements are stated in United States Dollars and are
prepared in accordance with United States Generally Accepted Accounting
Principles.

NINE-MONTH PERIOD ENDED SEPTEMBER 30, 2009 COMPARED TO THE NINE-MONTH PERIOD
ENDED SEPTEMBER 30, 2008.

Our net loss for the nine-month period ended September 30, 2009 was
approximately ($35,503) compared to a net loss of ($25,369) during the
nine-month period ended September 30, 2008. During the nine-month periods ended
September 30, 2009 and 2008, we did not generate any revenue.

During the nine-month period ended September 30, 2009, we incurred general and
administrative expenses of approximately $35,503 compared to $25,369 incurred
during the nine-month period ended September 30, 2008. General and
administrative expenses incurred during the nine-month period ended September
30, 2009 were generally related to corporate overhead, financial and
administrative contracted services, such as legal and accounting, developmental
costs, and marketing expenses.

Our net loss during the nine-month period ended September 30, 2009 was ($35,503)
or ($0.00) per share compared to a net loss of ($25,369) or ($0.00) per share
during the nine-month period ended September 30, 2008. The weighted average
number of shares outstanding was 81,81,000 for the nine-month periods ended
September 30, 2009 and 2008, respectively.

LIQUIDITY AND CAPITAL RESOURCES

NINE-MONTH PERIOD ENDED SEPTEMBER 30, 2009

As at the nine-month period ended September 30, 2009, our current assets were
$1,498 and our current liabilities were $21,418, which resulted in negative
working capital of $19,920. As of September 30, 2009, current assets were
comprised of $1,498 in cash compared to $15,783 at December 31, 2008.

At September 30, 2009 current liabilities were comprised entirely of $21,418 in
loan from a related party compared to $200 in current liabilities at December
31, 2008. The increase in liabilities during the nine-month period ended
September 30, 2009 from December 31, 2008 was primarily due to the loan
repayment to and additional loans from a related party.

Stockholders' equity decreased from $15,583 at December 31, 2008 to capital
deficiency of $(19,920) at September 30, 2009.

                                       12
<PAGE>
CASH FLOWS FROM OPERATING ACTIVITIES

We have not generated positive cash flows from operating activities. For the
nine-month period ended September 30, 2009, net cash flows used in operating
activities was ($35,503) consisting of a net loss of ($35,503). Net cash flows
used in operating activities was ($25,369) for the nine-month period ended
September 30, 2008.

CASH FLOWS FROM FINANCING ACTIVITIES

We have financed our operations primarily from either advancements or the
issuance of equity and debt instruments. For the nine-month period ended
September 30, 2009, net cash flows provided by financing activities was
($21,318) consisting primarily of ($100) loan repayment and additional loans of
$21,418. For the nine-month period ended September 30, 2008, we had not
generated cash flows from investing activities.

We expect that working capital requirements will continue to be funded through a
combination of our existing funds and further issuances of securities. Our
working capital requirements are expected to increase in line with the growth of
our business.

PLAN OF OPERATION AND FUNDING

Our cash reserves are not sufficient to meet our obligations for the next twelve
month period. As a result, we will need to seek additional funding in the near
future. We currently do not have a specific plan of how we will obtain such
funding; however, we anticipate that additional funding will be in the form of
equity financing from the sale of shares of our common stock. We may also seek
to obtain short-term loans from our directors, although no such arrangements
have been made. At this time, we cannot provide investors with any assurance
that we will be able to obtain sufficient funding from the sale of our common
stock or through a loan from our directors to meet our obligations over the next
twelve months. We do not have any arrangements in place for any future equity
financing.

MATERIAL COMMITMENTS

As of the date of this Quarterly Report, we have a material commitment for
fiscal year 2009. As of September 30, 2009, we owe related parties $21,418. The
amounts are non-interest bearing and payable upon demand.

PURCHASE OF SIGNIFICANT EQUIPMENT

We do not intend to purchase any significant equipment during the next twelve
months.

OFF-BALANCE SHEET ARRANGEMENTS

We do not have any off-balance sheet arrangements that have or are reasonably
likely to have a current or future effect on the small business issuer's
financial condition, changes in financial condition, revenues or expenses,
results of operations, liquidity, capital expenditures or capital resources that
are material to investors.

                                       13
<PAGE>
GOING CONCERN

The independent auditors' report accompanying our December 31, 2008 financial
statements contained an explanatory paragraph expressing substantial doubt about
our ability to continue as a going concern. The financial statements have been
prepared "assuming that we will continue as a going concern," which contemplates
that we will realize our assets and satisfy our liabilities and commitments in
the ordinary course of business.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Market risk represents the risk of loss that may impact our financial position,
results of operations or cash flows due to adverse change in foreign currency
and interest rates.

EXCHANGE RATE

Our reporting currency is United States Dollars ("USD"). The Russian Ruble has
been informally pegged to the USD. However, Russia is under international
pressure to adopt a more flexible exchange rate system. If the Russian Ruble was
no longer pegged to the USD, rate fluctuations may have a material impact on our
financial reporting and make realistic revenue projections difficult.

The fluctuation of exchange rates of the Ruble may have positive or negative
impacts on our results of operations. However, since all sales revenue and
expenses of our company will primarily denominated in U.S. Dollar, the net
income effect of appreciation and devaluation of the currency against the US
Dollar will be limited to our costs of acquisition of inventory.

INTEREST RATE

Interest rates in Russia are not generally controlled. Any future loans will
relate mainly to trade payables and will be mainly short-term. However our debt
may be likely to rise in connection with expansion and if interest rates were to
rise at the same time, this could become a significant impact on our operating
and financing activities. We have not entered into derivative contracts either
to hedge existing risks of for speculative purposes.

ITEM 4. CONTROLS AND PROCEDURES

Under the supervision and with the participation of our management, including
our principal executive officer and principal financial officer, we have
conducted an evaluation of the effectiveness of the design and operation of our
disclosure controls and procedures and defined in Rules 13a-15(e) and 15d-15(e)
under the Securities and Exchange Act of 1934, as of the end of the period
covered by this report. Based on this evaluation, our principal executive
officer and principal financial officer concluded as of the evaluation date,
that our disclosure controls and procedures were effective such that the
material information required to be included in our Securities and Exchange
Commission reports is recorded, processed, summarized and reported within the
time periods specified in SEC rules and forms relating to our Company,
particularly during the period when this report was being prepared.

                                       14
<PAGE>
Additionally, there were no significant changes in our internal controls or in
other factors that could significantly affect these controls subsequent to the
evaluation date. We have not identified any significant deficiencies or material
weakness in our internal controls and therefore there were no corrective actions
taken.

                           PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

We are not currently involved in any legal proceedings and we are not aware of
any pending or potential legal actions.

ITEM 2. CHANGES IN SECURITIES AND USE OF PROCEEDS

No report required.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

No report required.

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

No report required.

ITEM 5. OTHER INFORMATION

There was no information required to be disclosed on form 8-K during the period
covered by this report.

ITEM 6. EXHIBITS

     31.1 Certification of Chief Executive Officer pursuant to Securities
          Exchange Act of 1934 Rule 13a-14(a) or 15d-14(a).

     31.2 Certification of Chief Financial Officer pursuant to Securities
          Exchange Act of 1934 Rule 13a-14(a) or 15d-14(a).

     32.1 Certifications pursuant to Securities Exchange Act of 1934 Rule
          13a-14(b) or 15d- 14(b) and 18 U.S.C. Section 1350, as adopted
          pursuant to Section 906 of the Sarbanes- Oxley Act of 2002.

                                       15
<PAGE>
                                   SIGNATURES

Pursuant to the requirements of the Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.

                                         Bio-Clean, Inc., Registrant

Dated: November 20, 2009
                                         By: /s/ Darrin Holman
                                            ------------------------------------
                                             Chief Executive Officer



                                         By: /s/ Dale Paisley
                                            ------------------------------------
                                             Chief Financial Officer and
                                             Principal Accounting Officer


                                       16